Editorial: IL-27 in health and disease
Front Immunol
.
2023 Mar 31:14:1191228.
doi: 10.3389/fimmu.2023.1191228.
eCollection 2023.
Authors
Tomozumi Imamichi
1
,
Xue-Feng Bai
1
2
,
Cory Robinson
3
,
Katrina Gee
4
Affiliations
1
Applied Development and Research Directorate, Frederick National Laboratory for Cancer, Frederick, MD, United States.
2
Department of Pathology, College of Medicine, The Ohio State University, Columbus, OH, United States.
3
Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
4
Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
PMID:
37063840
PMCID:
PMC10102607
DOI:
10.3389/fimmu.2023.1191228
No abstract available
Keywords:
HIV; IL-27; Mycobacterium tuberculosis; cancer; inflammation.
Publication types
Editorial
Introductory Journal Article
MeSH terms
Humans
Interleukin-27*
Substances
Interleukin-27